Latest News
CityUHK and Pharmaron (Hong Kong) International Limited (Pharmaron) signed a Collaborative Framework Agreement on 17 October 2025, whose aim is to foster talent incubation, digital medicine innovation and knowledge sharing.
Four research teams from City University of Hong Kong (CityUHK) were awarded funding as part of the second batch of projects under the “Research, Academic and Industry Sectors One-plus Scheme (RAISe+) Scheme”. The projects encompass groundbreaking advancements in new materials, new energy, electrical and electronic engineering, and health and medical sciences.
City University of Hong Kong (CityUHK) and Huadong Hospital, affiliated with Fudan University in Shanghai (Huadong Hospital), officially established the “CityUHK – Huadong Hospital Joint Research Institute of Smart Healthcare” (the Joint Research Institute) in Shanghai
Genome editing is increasingly recognised as a leading frontier in biomedical research and an essential driver of healthcare innovation. At City University of Hong Kong (CityUHK), a research team has been awarded funding under the “RAISe+ Scheme”
City University of Hong Kong (CityUHK) signed a Memorandum of Understanding (MoU) with Sinovation Ventures on September 10, 2025.